Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy [1]

Blood

Volumn 107, Issue 11, 2006, Pages 4570-4571

  Semmo, Nasser ^b   Lucas, Michaela ^b   Krashias, George ^b   Lauer, Georg ^b   Chapel, Helen ^b   Klenerman, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBODY; ANTIVIRUS AGENT;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; ENZYME LINKED IMMUNOSPOT ASSAY; HEPATITIS C; HUMAN; INFECTION; LETTER; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 33744494806     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-11-4522     Document Type: Letter

References (5)

1. Chapel HM, Christie JM, Peach V, Chapman RW. Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C. Clin Immunol. 2001;99:320-324.
2. Christie JM, Healey CJ, Watson J, et al. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up. Clin Exp Immunol. 1997;110:4-8.
3. Lauer G, Barnes E, Lucas M, et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004;127:924-936.
4. Semmo N, Day CL, Ward SM, et al. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology. 2005;41:1019-1028.
5. Mannering SI, Morris JS, Jensen KP, et al. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J Immunol Methods. 2003;283:173-183.